ScholarIQanswers from OpenAlex & ORCID
David A. Bushinsky
ResearcherPublications, citations & collaboration network
David A. Bushinsky is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David A. Bushinsky have?
ScholarIQindexed works
David A. Bushinsky has 339 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David A. Bushinsky have?
ScholarIQcitation count
David A. Bushinsky has 16,134 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David A. Bushinsky?
ScholarIQh-index
David A. Bushinsky has an h-index of 70 in OpenAlex.
What is the i10-index of David A. Bushinsky?
ScholarIQi10-index
David A. Bushinsky has an i10-index of 199 in OpenAlex.
What is the ORCID of David A. Bushinsky?
ScholarIQorcid
The ORCID for David A. Bushinsky is on the source record.
What is the OpenAlex record for David A. Bushinsky?
ScholarIQopenalex
The OpenAlex for David A. Bushinsky is on the source record.
What are the most-cited papers on David A. Bushinsky?
ScholarIQmost cited works
Hospital-acquired renal insufficiency: A prospective study
Susan Hou, David A. Bushinsky, Jay B. Wish, Jordan J. Cohen, John T. Harrington
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Matthew R. Weir, George L. Bakris, David A. Bushinsky, Martha Mayo, Dahlia Garza, Yuri Stasiv, Janet Wittes, Heidi Christ‐Schmidt, Lance Berman, Bertram Pitt
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
Bertram Pitt, Stefan D. Anker, David A. Bushinsky, Dalane W. Kitzman, Faı̈ez Zannad, I‐Zu Huang, on behalf of the PEARL-HF Investigators
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease
George L. Bakris, Bertram Pitt, Matthew R. Weir, Mason W. Freeman, Martha Mayo, Dahlia Garza, Yuri Stasiv, Rezi Zawadzki, Lance Berman, David A. Bushinsky
Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease
Dominique P. Germain, Stephen Waldek, Maryam Banikazemi, David A. Bushinsky, Joel Charrow, Robert J. Desnick, Philip Lee, Thomas Loew, Anouk C. Vedder, Rekha Abichandani, William R. Wilcox, Nathalie Guffon